Bruker Group of Cos., Aurora to Invest in Integrative Proteomics | GenomeWeb

NEW YORK, May 15 – Integrative Proteomics said Tuesday that four companies are planning to take equity stakes in the Toronto-based company.

Bruker AXS, Bruker BioSpin, Bruker Daltonics, and Aurora Biosciences all plan to make a strategic equity investment in Integrative Proteomics, the company mentioned in a statement announcing the company’s recent activities. Integrative Proteomics did not offer any details about the size of the stakes. A spokeswoman was not immediately available for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.